November 3, 2022 11:06 AM EDTUpdated November 4, 02:10 PM
Manufacturing

Man­u­fac­tur­ing roundup: Teru­mo Phar­ma­ceu­ti­cal So­lu­tions ex­pand­ing CD­MO reach out­side Japan; EU­ROAPI boost­ing pro­duc­tion at Frank­furt site

Tyler Patchen

News Reporter

The CD­MO arm of the Teru­mo Cor­po­ra­tion is look­ing to branch out of Japan and of­fer its ser­vices in oth­er na­tions.

Teru­mo Phar­ma­ceu­ti­cal So­lu­tions will …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times